Industry Developments

BMI View: Although creating and maintaining equitable access to medical services across the Bahamas has proven difficult, we are encouraged by the government's pledge to match its investment... 2011-11-25

BMI View: While Venezuela's decision to formally regulate margins on goods and services, including healthcare, is likely to help President Hugo Chávez win political support and control... 2011-11-24

BMI View: Although the Honduran Ministry of Health has promised to have fair and transparent bidding for tenders, we believe the country's business environment fosters a system that... 2011-11-23

BMI Core View: Political stability, a cost-effective healthcare system and an established tourism sector are the fundamental prerequisites for developing a medical tourism industry.... 2011-11-22

BMI View: Long viewed as a refuge for leading drugmakers, government cost-cutting measures, including the promotion of generics and branded product price reductions, are expected to... 2011-11-21

BMI Core View: Drugmakers will increasingly use differential pricing in emerging markets. Pharmaceutical companies generally price their patented medicines at the maximum the market... 2011-11-18

BMI View: While the rise in prescription drug abuse in Colombia has previously been attributed to unethical prescribing and strong consumer demand, BMI believes the International Narcotics... 2011-11-17

BMI View: Although Cuba's conservative healthcare strategy has helped it rank remarkably well on basic indicators, we note the country, and more importantly its ordinary patients, will... 2011-11-16

BMI View: Just months after Mexico's government initiated a nation-wide crackdown on over-the-counter (OTC) medicines, it seems pressure from pharmaceutical manufacturers and pharmacy... 2011-11-11

BMI Core View: Drugmakers based in emerging markets will expand their presence in developed countries. Firms in developing countries enjoy low operating costs but have historically... 2011-11-10